ArticleJournal of enzyme inhibition and medicinal chemistry2025
Targeting MED8 enhances sorafenib sensitivity in hepatocellular carcinoma by disrupting epithelial-mesenchymal transition mechanisms.
Ming Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.